Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Intervalo de año de publicación
3.
J Virol ; 90(14): 6326-6343, 2016 07 15.
Artículo en Inglés | MEDLINE | ID: mdl-27147733

RESUMEN

UNLABELLED: Nipah virus (NiV) is a highly lethal paramyxovirus that recently emerged as a causative agent of febrile encephalitis and severe respiratory disease in humans. The ferret model has emerged as the preferred small-animal model with which to study NiV disease, but much is still unknown about the viral determinants of NiV pathogenesis, including the contribution of the C protein in ferrets. Additionally, studies have yet to examine the synergistic effects of the various P gene products on pathogenesis in animal models. Using recombinant NiVs (rNiVs), we examine the sole contribution of the NiV C protein and the combined contributions of the C and W proteins in the ferret model of NiV pathogenesis. We show that an rNiV void of C expression resulted in 100% mortality, though with limited respiratory disease, like our previously reported rNiV void of W expression; this finding is in stark contrast to the attenuated phenotype observed in previous hamster studies utilizing rNiVs void of C expression. We also observed that an rNiV void of both C and W expression resulted in limited respiratory disease; however, there was severe neurological disease leading to 60% mortality, and the surviving ferrets demonstrated sequelae similar to those for human survivors of NiV encephalitis. IMPORTANCE: Nipah virus (NiV) is a human pathogen capable of causing lethal respiratory and neurological disease. Many human survivors have long-lasting neurological impairment. Using a ferret model, this study demonstrated the roles of the NiV C and W proteins in pathogenesis, where lack of either the C or the W protein independently decreased the severity of clinical respiratory disease but did not decrease lethality. Abolishing both C and W expression, however, dramatically decreased the severity of respiratory disease and the level of destruction of splenic germinal centers. These ferrets still suffered severe neurological disease: 60% succumbed to disease, and the survivors experienced long-term neurological impairment, such as that seen in human survivors. This new ferret NiV C and W knockout model may allow, for the first time, the examination of interventions to prevent or mitigate the neurological damage and sequelae experienced by human survivors.


Asunto(s)
Endotelio Vascular/patología , Infecciones por Henipavirus/complicaciones , Virus Nipah/patogenicidad , Fosfoproteínas/inmunología , Enfermedades Respiratorias/etiología , Proteínas Virales/inmunología , Animales , Anticuerpos Antivirales/inmunología , Células Cultivadas , Chlorocebus aethiops , Cricetinae , Endotelio Vascular/inmunología , Endotelio Vascular/metabolismo , Femenino , Hurones , Infecciones por Henipavirus/inmunología , Infecciones por Henipavirus/virología , Humanos , Enfermedades Respiratorias/patología , Células Vero , Carga Viral
4.
Curr Top Microbiol Immunol ; 359: 41-58, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22552699

RESUMEN

Nipah (NiV) and Hendra (HeV) viruses comprise the genus Henipavirus and are highly pathogenic paramyxoviruses, which cause fatal encephalitis and respiratory disease in humans. Since their respective initial outbreaks in 1998 and 1994, they have continued to cause sporadic outbreaks resulting in fatal disease. Due to their designation as Biosafety Level 4 pathogens, the level of containment required to work with live henipaviruses is available only to select laboratories around the world. This chapter provides an overview of the molecular virology of NiV and HeV including comparisons to other, well-characterized paramyxoviruses. This chapter also describes the sequence diversity present among the henipaviruses.


Asunto(s)
Genoma Viral , Virus Hendra/genética , Virus Nipah/genética , Proteínas Virales/genética , Animales , Quirópteros/virología , Encefalitis Viral/complicaciones , Encefalitis Viral/virología , Variación Genética , Tamaño del Genoma , Virus Hendra/clasificación , Virus Hendra/aislamiento & purificación , Infecciones por Henipavirus/complicaciones , Infecciones por Henipavirus/virología , Caballos/virología , Humanos , Virus Nipah/clasificación , Virus Nipah/aislamiento & purificación , Filogenia , Genética Inversa , Replicación Viral
5.
Curr Top Microbiol Immunol ; 359: 95-104, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22427144

RESUMEN

The clinicopathological features of human Nipah virus and Hendra virus infections appear to be similar. The clinical manifestations may be mild, but if severe, includes acute encephalitic and pulmonary syndromes with a high mortality. The pathological features in human acute henipavirus infections comprise vasculopathy (vasculitis, endothelial multinucleated syncytia, thrombosis), microinfarcts and parenchymal cell infection in the central nervous system, lung, kidney and other major organs. Viral inclusions, antigens, nucleocapsids and RNA are readily demonstrated in blood vessel wall and numerous types of parenchymal cells. Relapsing henipavirus encephalitis is a rare complication reported in less than 10% of survivors of the acute infection and appears to be distinct from the acute encephalitic syndrome. Pathological evidence suggests viral recrudescence confined to the central nervous system as the cause.


Asunto(s)
Vasos Sanguíneos/patología , Sistema Nervioso Central/patología , Encefalitis Viral/patología , Infecciones por Henipavirus/patología , Infarto del Miocardio/patología , Miocardio/patología , Animales , Vasos Sanguíneos/virología , Sistema Nervioso Central/virología , Encefalitis Viral/complicaciones , Encefalitis Viral/mortalidad , Encefalitis Viral/virología , Virus Hendra/patogenicidad , Virus Hendra/fisiología , Infecciones por Henipavirus/complicaciones , Infecciones por Henipavirus/mortalidad , Infecciones por Henipavirus/virología , Humanos , Riñón/patología , Riñón/virología , Pulmón/patología , Pulmón/virología , Infarto del Miocardio/complicaciones , Infarto del Miocardio/mortalidad , Infarto del Miocardio/virología , Virus Nipah/patogenicidad , Virus Nipah/fisiología , Tasa de Supervivencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...